Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Hlds Inc (NQ: OGI )

1.580 -0.070 (-4.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organigram Hlds Inc

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
7 Robinhood Stocks You Can Still Buy for Under $5
Although 2021 has been a blistering year for equities, there are still some speculative Robinhood stocks to buy under $5. 
Via InvestorPlace
Cannabis Stock Gainers And Losers From January 18, 2022
GAINERS: Item 9 Labs (OTC: 
Via Benzinga
Organigram Q1 Financial Report Shows Major Improvements
An analysis of OGI's Q1 financial results compared to the results of the previous quarter. 
Via Talk Markets
Model Update For OrganiGram Holdings: 'Discount To Larger Peers Is Overdone'
Pablo Zuanic, analyst at Cantor Fitzgerald, offered an updated investment model for OrganiGram (TSE: OGI) (NASDAQ:... 
Via Benzinga
Value Cannabis Stocks To Watch
The Best Daily Overview Of The Cannabis Space On today's 
Via Benzinga
Recap: OrganiGram Holdings Q1 Earnings
OrganiGram Holdings (NASDAQ:OGI) reported its Q1 earnings results on Tuesday, January 11, 2022 at 06:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Organigram Clocks Highest Quarterly Net Revenue In Q1
Organigram Holdings Inc (NASDAQ: OGI) has posted Q1 FY22 net revenue of $30.4 million, the highest quarterly net revenue in the company's history at 22% growth... 
Via Benzinga
Organigram Reports First Quarter Fiscal 2022 Results
From Organigram Holdings Inc.
Via Business Wire
Earnings Scheduled For January 11, 2022
Companies Reporting Before The Bell • OrganiGram Holdings (NASDAQ:OGI) is projected to report quarterly loss at $0.02 per share on revenue of $23.95 million. •... 
Via Benzinga
OrganiGram Holdings Earnings Preview
OrganiGram Holdings (NASDAQ:OGI) is set to give its latest quarterly earnings report on Tuesday, 2022-01-11. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Earnings Outlook For OrganiGram Holdings
OrganiGram Holdings (NASDAQ:OGI) is set to give its latest quarterly earnings report on Tuesday, 2022-01-11. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
The "Seed-To-Sale" Pot Stocks Index Is Down 67% Off Its 2021 High
The 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 5, 2022
GAINERS: Rhinomed (OTC: 
Via Benzinga
Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022
From Organigram Holdings Inc.
Via Business Wire
Cannabis Stock Gainers And Losers From January 4, 2022
GAINERS: Icanic Brands (OTC: 
Via Benzinga
Year-End Summary: "Seed-To-Sale" Pot Stocks Index Down -33.7% In 2021
The Canadian LPs segment won the race to the bottom, going down -48.2% in 2021 compared to the American MSOs segment which went down 
Via Talk Markets
Cannabis Stock Gainers And Losers From January 3, 2022
GAINERS: BioHarvest Sciences (OTC: 
Via Benzinga
The Canadian Cannabis Report - Monday, Jan. 3
The past, present, and future of the Canadian cannabis sector based on the MCCCI, which is a proprietary 22 stock index. 
Via Talk Markets
The Canadian Cannabis Company Index Report Review For 2021
Given the uncertainty of passage of legislation favorable to the cannabis sector, I am agnostic about how it will perform in 2022. 
Via Talk Markets
Organigram Holdings Had A Pretty Strong 2021 And Are Full Steam Ahead Going Into 2022
Earlier this year, Organigram Holdings Inc. received a large investment from a leading tobacco conglomerate and we saw a spike in interest in the Canadian Licensed Producer (LP) after the... 
Via Talk Markets
Organigram Invests Additional $2.5M In CBD Biotech Co Hyasynth, Wraps Up $10M Debenture Purchase Deal
Organigram Holdings Inc. (NASDAQ:OGI) (TSX: 
Via Benzinga
Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company
From Organigram Holdings Inc.
Via Business Wire
Organigram Stock Up On $36M Acquisition Of Quebec-Based Craft Cannabis, Hash Producer
Cannabis producer Organigram Holdings Inc. (TSX:OGI)(NASDAQ: 
Via Benzinga
Organigram Acquires Quebec-Based Laurentian Organic Inc. in Accretive Transaction
From Organigram Holdings Inc.
Via Business Wire
Cannabis Stocks Racing To Bottom: DOWN -17% So Far In December
The 
Via Talk Markets
The Conservative Pot Stocks Index Continues To Outperform
Seed-to-sale cannabis stocks are -35.0% YTD. But the tobacco, beer and liquor companies that have invested heavily in the cannabis industry are still +5.3% YTD, in comparison, and pay dividends to... 
Via Talk Markets
Another Conservative Way To Indirectly Invest In The Cannabis Sector
If you are reluctant to invest directly in cannabis stocks given that the sector is down -30.5% YTD, consider these companies that have invested heavily in the cannabis industry, or the VICE ETF. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Why OrganiGram, Hexo, and Green Thumb Industries Were Surging Today
Cannabis companies got a bit of relief after their months-long share price swoons, but whether or not they'll get near-term help from Congress remains unclear. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Dec. 6
For the trading week ended December 3, there was a decrease of 12.4% decrease in my proprietary Canadian Cannabis Company Index (MCCCI) compared to the prior week when there was an increase of 1.1%. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The MunKNEE "Seed-To-Sale" Pot Stocks Index Continued To Decline In November
The munKNEE Pure-Play 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.